|
15 Oct 2025 |
Lemon Tree Hotels
|
Consensus Share Price Target
|
161.63 |
178.24 |
- |
10.28 |
buy
|
|
|
|
|
14 Nov 2022
|
Lemon Tree Hotels
|
Motilal Oswal
|
161.63
|
110.00
|
91.00
(77.62%)
|
Target met |
Buy
|
|
|
|
|
14 Nov 2022
|
Lemon Tree Hotels
|
ICICI Securities Limited
|
161.63
|
120.00
|
91.25
(77.13%)
|
Target met |
Buy
|
|
|
Lemon Tree Hotels (LTH) reported Q2FY23 consolidated revenue of Rs1.9bn (up 2% QoQ) which was marginally higher than I-sec estimate of Rs1.8bn with reported EBITDA of Rs0.9bn at EBITDA margins of 47.6% (I-sec estimate of 47%).
|
|
02 Sep 2022
|
Lemon Tree Hotels
|
Ventura
|
161.63
|
91.60
|
73.25
(120.66%)
|
Target met |
Buy
|
|
|
Sweet lemonade for your portfolio
|
|
05 Aug 2022
|
Lemon Tree Hotels
|
ICICI Direct
|
161.63
|
95.00
|
72.85
(121.87%)
|
Target met |
Buy
|
|
|
|
|
04 Aug 2022
|
Lemon Tree Hotels
|
Motilal Oswal
|
161.63
|
90.00
|
72.85
(121.87%)
|
Target met |
Buy
|
|
|
|
|
11 Jul 2022
|
Lemon Tree Hotels
|
Motilal Oswal
|
161.63
|
86.00
|
65.80
(145.64%)
|
Target met |
Buy
|
|
|
|
|
01 Jun 2022
|
Lemon Tree Hotels
|
ICICI Direct
|
161.63
|
78.00
|
65.90
(145.27%)
|
Target met |
Buy
|
|
|
|
|
01 Jun 2022
|
Lemon Tree Hotels
|
ICICI Securities Limited
|
161.63
|
84.00
|
64.20
(151.76%)
|
Target met |
Buy
|
|
|
Lemon Tree Hotels’ (LTH) Q4FY22 results reflect clear signs of recovery in room occupancy and rates as Mar’22 occupancies have risen to 60% and Q4FY22 gross ARR was at 90% of Q4FY20 levels. As per company, overall ARR has already crossed Rs5,000 in May’22 with business travel showing strong uptick.
|
|
30 May 2022
|
Lemon Tree Hotels
|
Motilal Oswal
|
161.63
|
85.00
|
64.20
(151.76%)
|
Target met |
Buy
|
|
|
|
|
13 Feb 2022
|
Lemon Tree Hotels
|
Motilal Oswal
|
161.63
|
68.00
|
47.20
(242.44%)
|
Target met |
Buy
|
|
|
LEMONTRE reported a better than expected sales and EBITDA. Revenue grew 2.1x YoY in 3QFY22, led by robust (+109%) RevPAR growth on account of a 15pp improvement in occupancy and 54% growth in ARR. EBITDA surged 3.2x YoY, benefitting from operating leverage. We decrease our FY22E/FY23E EBITDA estimate by 14%/13%, factoring in...
|